Arkolith/Insider Trading/ATXS/Form 4

Perceptive Life Sciences Master Fund Ltd

DirectorAstria Therapeutics, Inc. (ATXS) · full profile →Form 4 · filed Oct 18, 2023
Net Buying
Open-Market Buys
$7.0M
Open-Market Sells
$0
Net Open-Market Flow
$7.0M
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 16, 2023Buy(P)614K$6.51$4.0M1.7M
Oct 16, 2023Buy(P)461K$6.51$3.0M1.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 16, 2023Buy(P)461K$6.51$3.0M345K
Oct 16, 2023Buy(P)921K$6.51$6.0M921K
Oct 16, 2023Buy(P)921K$6.51$6.0M1.2M
Oct 16, 2023Buy(P)614K$6.51$4.0M461K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-23-019533) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML